IL6 and pancreatic neoplasm: Blocking IL-6/STAT3 signaling by anti-IL-6 antibodies or STAT3 inhibitor (NSC74859) disturbed stellate cell-induced migration and expression of mesenchymal markers in pancreatic cancer cells (27).